View Healthcare & Life Sciences Portfolio
Back to Portfolio

Viroclinics Biosciences

Specialized clinical trial / diagnostic services
Invested in
2019
Status

Acquired by Cerba Healthcare 2022

Location
Rotterdam, The Netherlands
Sector
Healthcare & Life Sciences
Sector
Growth Products & Services
Website
http://www.viroclinics.com

|

Viroclinics Biosciences is a leading provider of specialized clinical and non-clinical services to the global virology therapeutics and vaccine development market. The company offers a full range of services to support and accelerate the market entry of new drugs, vaccines and antivirals from discovery to launch.

How Summit Partners Helped

Related News

Portfolio Company News
summit news
CRO Industry Leader Davide Molho Joins Summit Partners as Executive-in-Residence
2022-11-10
Portfolio Company News
summit news
Cerba Healthcare to Acquire Viroclinics-DDL Expanding and Transforming Its Offering in Clinical Trials
2021-12-16
Portfolio Company News
summit news
Summit Partners Announces Growth Equity Investment in Viroclinics Biosciences
2020-03-03
Sector Insights
How Viroclinics-DDL is Accelerating the Development of Antiviral Therapies and Vaccines Worldwide
2021-06-28
Button Text

Get the Latest from Summit Partners

Subscribe to our newsletter to stay up to date on our partners, portfolio, and more.

Growth Products & Services
Life Sciences